Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 317

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Analysis of MiR-195 and MiR-497 Expression, Regulation and Role in Breast Cancer

Open access
Li, Dan, Zhao, Yulan, Liu, Changxing, Chen, Xiaona, Qi, Yanting, Jiang, Yue, Zou, Chao, Zhang, Xiaolong, Liu, Shunying, Wang, Xuejing, Zhao, Dan, Sun, Qiang, Zeng, Zhenbing, Dress, Andreas, Lin, Marie C., Kung, Hsiang-Fu, Rui, Hallgeir, Liu, Ling-Zhi, Mao, Feng, Jiang, Bing-Hua, Lai, Lihui · 2011 · Clinical Cancer Research

Published version of a preprint

Abstract

Purpose: To investigate expression, regulation, potential role and targets of miR-195 and miR-497 in breast cancer. Experimental Design: The expression patterns of miR-195 and miR-497 were initially examined in breast cancer tissues and cell lines by Northern blotting and quantitative real-time PCR. Combined bisulfite restriction analysis and bisulfite sequencing were carried out to study the DNA methylation status of miR-195 and miR-497 genes. Breast cancer cells stably expressing miR-195 and miR-497 were established to study their role and targets. Finally, normal, fibroadenoma and breast cancer tissues were employed to analyze the correlation between miR-195/497 levels and malignant stages of breast tumor tissues. Results: MiR-195 and miR-497 were significantly downregulated in breast cancer. The methylation state of CpG islands upstream of the miR-195/497 gene was found to be responsible for the downregulation of both miRNAs. Forced expression of miR-195 or miR-497 suppressed breast cancer cell proliferation and invasion. Raf-1 and Ccnd1 were identified as novel direct targets of miR-195 and miR-497. miR-195/497 expression levels in clinical specimens were found to be correlated inversely with malignancy of breast cancer. Conclusions: Our data imply that both miR-195 and miR-497 play important inhibitory roles in breast cancer malignancy and may be the potential therapeutic and diagnostic targets. Clin Cancer Res; 17(7); 1722–30. ©2011 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-10-1800

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 35 references

Research works printed but not linked: 1

  1. Vasudevan, 2007, Switching from repression to activation: microRNAs can up-regulate translation, Science, 318, 1931, 10.1126/science.1149460 · DOI · Paper page

Cited by

See all 317

Metadata

Authors
Li, D., Zhao, Y., Liu, C., Chen, X., Qi, Y., Jiang, Y., Zou, C., Zhang, X., Liu, S., Wang, X., Zhao, D., Sun, Q., Zeng, Z., Dress, A., Lin, M. C., Kung, H.-F., Rui, H., Liu, L.-Z., Mao, F., Jiang, B.-H., & Lai, L.
Venue
Clinical Cancer Research
Published
2011-03-31
Volume
17
Issue
7
Pages
1722-1730
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2122994524
Cited by
317
References
35
FWCI
7.65
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Analysis of MiR-195 and MiR-497 Expression, Regulation and Role in Breast Cancer. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-10-1800
The paper
Li, D., Zhao, Y., Liu, C., Chen, X., Qi, Y., Jiang, Y., Zou, C., Zhang, X., Liu, S., Wang, X., Zhao, D., Sun, Q., Zeng, Z., Dress, A., Lin, M. C., Kung, H.-F., Rui, H., Liu, L.-Z., Mao, F., . . . Lai, L. (2011). Analysis of MiR-195 and MiR-497 Expression, Regulation and Role in Breast Cancer. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-10-1800

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.